International Biotechnology Trust (IBT)

Category Sector Equity Biotechnology


star-filledstar-filledstar-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

710.00p

Buy

716.00p

arrow-up6.00p (+0.85%)

Discount/Premium

-9.57%

Estimated NAV

791.744p

Prices updated at 24 Jan 2025, 16:45 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

arrow-down-0.64%
LSE

Portfolio as of 31/12/2024

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Top 10 holdings

1
Scb Sholo211123b 27-Sep-2024 5.98% 28-Oct-2024
Sector
-
Country
-
% of assets
8.35912
2
Vera Therapeutics Inc Class A
Sector
-
Country
United States
% of assets
5.87109
3
Intra-Cellular Therapies Inc
Sector
-
Country
United States
% of assets
5.12698
4
Supernus Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
4.45618
5
Regeneron Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
3.6464
6
Sv Fund Vi Investment
Sector
-
Country
-
% of assets
3.60048
7
Sv Bcof
Sector
-
Country
-
% of assets
3.5621
8
Ascendis Pharma AS ADR
Sector
-
Country
Denmark
% of assets
3.36242
9
Insmed Inc
Sector
-
Country
United States
% of assets
2.85469
10
Neurocrine Biosciences Inc
Sector
-
Country
United States
% of assets
2.81813
Assets in top 10 holdings %

43.66%

Total no. of equity holdings

82.00

Total no. of bond holdings

-

Stock sectors

International Biotechnology Trust
Sector Equity Biotechnology

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

100.00%

Con defensive

-
-

Healthcare

100.00%
-

Utilities

-
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.